Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine

Documenti analoghi

• Post-Catalytic Complexes with Emtricitabine or Stavudine and HIV-1 Reverse Transcriptase Reveal New Mechanistic Insights for Nucleotide Incorporation and Drug Resistance
  di: Nicole Bertoletti, et al.
  Pubblicazione: (2020-10-01)
• Post-Catalytic Complexes with Emtricitabine or Stavudine and HIV-1 Reverse Transcriptase Reveal New Mechanistic Insights for Nucleotide Incorporation and Drug Resistance
  di: Bertoletti, Nicole, et al.
  Pubblicazione: (2020)
• Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors
  di: Hurwitz, Selwyn J., et al.
  Pubblicazione: (2012)
• Centrosome Amplification Induced by the Antiretroviral Nucleoside Reverse Transcriptase Inhibitors Lamivudine, Stavudine and Didanosine
  di: Yu, Mia, et al.
  Pubblicazione: (2009)
• Inhibition of multi-drug resistant HIV-1 reverse transcriptase by nucleoside β-triphosphates
  di: Dash, Chandravanu, et al.
  Pubblicazione: (2011)